News Releases

Einstein-Created Drugs Show Promise Against an Incurable Eye Disease
Study Finds That an Autism Deficit May 'Disappear' in Adulthood
Einstein Researchers Awarded $3.5 Million NIH Grant to Study Brain Changes Caused by COVID-19

Facts & Stats

Published Papers
NIH Research Funding
Students
Full-time Faculty
Global Initiatives
Clinical and Research Centers
Alumni

Expert List for Media

Kartik Chandran

Kartik Chandran, Ph.D.

Area(s) of expertise: COVID-19, Ebola, and emerging virusesAntibody-based therapiesAnti-viral therapeutics

A recognized expert on emerging viruses, Dr. Chandran studies how viruses infect cells, and his research seeks to translate this knowledge into new antibody-based therapies. In 2020, Dr. Chandran helped lead Einstein’s research on COVID-19: Within weeks of the global… Learn more

Einstein in the News


BronxNet
Effects of COVID-19 on the Brain

Michael Lipton, M.D., Ph.D., and Johanna Daily, M.D., M.S., discuss their National of Institutes Health grant to study how COVID-19 affects brain function in young adults who had mild or asymptomatic infection. Dr. Lipton is associate director of the Gruss Magnetic Resonance Research Center at Einstein and medical director of MRI services at Montefiore. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.

More coverage on Dr. LiptonMore coverage on Dr. Daily

MedPageToday
Bust for Balovaptan in Treatment of Childhood Autism

Eric Hollander, M.D., discusses results of a large, randomized clinical trial that found the drug balovaptan did not improve socialization and communication among those with pediatric autism spectrum disorder (ASD). Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore and Einstein. 

Additional coverage includes Medscape

More coverage on Dr. Hollander

The City
NYC Doctors, Doulas, Activists Prep For a Massive Influx of Abortion Seekers

Antoinette Danvers, M.D., explains the importance of abortion training and Montefiore and Einstein's efforts to offer it to medical residents in states where abortion is now illegal. Dr. Danvers is associate professor of obstetrics & gynecology and women's health at Einstein and director of the division of complex family planning at Montefiore.

Multimedia

When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog